Silk Road Medical Inc [SILK] stock prices are down -0.26% to $26.97 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SILK shares have gain 0.07% over the last week, with a monthly amount glided 28.00%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Silk Road Medical Inc [NASDAQ: SILK] stock has seen the most recent analyst activity on March 07, 2024, when Argus upgraded its rating to a Buy but kept the price target unchanged to $24 for it. Previously, Stifel upgraded its rating to Buy on January 19, 2024, and elevated its price target to $20. On January 03, 2024, Lake Street initiated with a Buy rating and assigned a price target of $20 on the stock. Wolfe Research upgraded its rating to a Peer Perform. Stifel downgraded its rating to a Hold and reduced its price target to $12 on October 11, 2023. CL King downgraded its rating to Neutral for this stock on October 11, 2023. In a note dated October 11, 2023, Citigroup downgraded an Sell rating on this stock and revised its target price from $35 to $8.
The stock price of Silk Road Medical Inc [SILK] has been fluctuating between $6.08 and $33.12 over the past year. Currently, Wall Street analysts expect the stock to reach $30.58 within the next 12 months. Silk Road Medical Inc [NASDAQ: SILK] shares were valued at $26.97 at the most recent close of the market. An investor can expect a potential return of 13.39% based on the average SILK price forecast.
Analyzing the SILK fundamentals
The Silk Road Medical Inc [NASDAQ:SILK] reported sales of 185.49M for trailing twelve months, representing a surge of 20.81%. Gross Profit Margin for this corporation currently stands at 0.73% with Operating Profit Margin at -0.31%, Pretax Profit Margin comes in at -0.29%, and Net Profit Margin reading is -0.29%. To continue investigating profitability, this company’s Return on Assets is posted at -0.21, Equity is -0.35 and Total Capital is -0.25. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.53.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.92 points at the first support level, and at 26.87 for the second support level. However, for the 1st resistance point, the stock is sitting at 27.03, and for the 2nd resistance point, it is at 27.09.
Ratios To Look Out For
It’s worth pointing out that Silk Road Medical Inc [NASDAQ:SILK]’s Current Ratio is 11.05. As well, the Quick Ratio is 9.62, while the Cash Ratio is 1.06. Considering the valuation of this stock, the price to sales ratio is 5.78, the price to book ratio is 7.22.
Transactions by insiders
Recent insider trading involved Davis Andrew S., Chief Commercial Officer, that happened on Jul 03 ’24 when 66.0 shares were sold. Director, Ballinger Kevin J. completed a deal on Mar 05 ’24 to buy 11700.0 shares. Meanwhile, COO/CFO Buchanan Lucas W. sold 9877.0 shares on Mar 05 ’24.
